RIL
FENC icon

Rothschild Investment LLC’s Fennec Pharmaceuticals FENC Stock Holding History

Rothschild Investment LLC’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$656 Buy
61
+42
+221% +$343 ﹤0.01% 3203
2026
Q1 		$117 Buy
+19
New +$147 ﹤0.01% 3379

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCA
Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Rothschild Investment LLC's FENC Position: Q2 2026 in Review

Rothschild Investment LLC increased its Fennec Pharmaceuticals (FENC) stake by 221% in Q2 2026, buying an estimated $343 and bringing the position to 61 shares worth $656. The position accounts for ﹤0.01% of the portfolio, ranked #3203.

Rothschild Investment LLC first reported a position in FENC in Q1 2026 and has held it in 2 quarters since. 105 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • Rothschild Investment LLC held 61 shares of Fennec Pharmaceuticals worth $656 as of Q2 2026.
  • Rothschild Investment LLC bought 42 Fennec Pharmaceuticals shares in Q2 2026, an estimated $343.
  • Fennec Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #3203 holding.
  • Rothschild Investment LLC first reported a position in Fennec Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 105 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.